Is there evidence that estrogen therapy promotes weight maintenance via effects on leptin?

Menopause

Volumn 21, Issue 4, 2014, Pages 424-432

  Springer, Alyse M ^a   Foster Schubert, Karen ^a   Morton, Gregory J ^b   Schur, Ellen A ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Diabetes and Obesity Center of Excellence   (United States)

Author keywords

Estrogen; Hormone therapy; Leptin; Obesity

Indexed keywords

ESTRADIOL; LEPTIN; NORETHISTERONE; PLACEBO; RALOXIFENE; TIBOLONE; ESTROGEN;

BODY FAT; BODY WEIGHT; ESTROGEN THERAPY; FAT MASS; FOLLOW UP; HORMONE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; MEDLINE; OBESITY; OVARIECTOMY; POSTMENOPAUSE; REVIEW; WEIGHT GAIN; ANIMAL; BLOOD; BODY MASS; DRUG EFFECTS; FEMALE; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ADIPOSITY; ANIMALS; BODY MASS INDEX; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; LEPTIN; MEDLINE; OBESITY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; WEIGHT GAIN;

EID: 84897518202     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/GME.0000000000000117     Document Type: Review

References (48)

1. Leibel RL, Rosenbaum M, Hirsch J. Changes in energy expenditure resulting from altered body weight. N Engl J Med 1995;332:621-628.
2. Stanley S,Wynne K, McGowan B, Bloom S. Hormonal regulation of food intake. Physiol Rev 2005;85:1131-1158.
3. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-432.
4. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactiveleptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334:292-295.
5. Schwartz MW, Peskind E, Raskind M, Boyko EJ, Porte D Jr. Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nat Med 1996;2:589-593.
6. Pelleymounter MA, Baker MB, McCaleb M. Does estradiol mediate leptin's effects on adiposity and body weight? Am J Physiol Endocrinol Metab 1999;276:E955-E963.
7. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995;269:546-549.
8. Halaas JL, Gajiwala KS, Maffei M, et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995;269:543-546.
9. Montague CT, Farooqi IS, Whitehead JP, et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997;387:903-908.
10. Lee GH, Proenca R, Montez JM, et al. Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996;379:632-635.
11. Matsuoka N, Ogawa Y, Hosoda K, et al. Human leptin receptor gene in obese Japanese subjects: evidence against either obesity-causing mutations or association of sequence variants with obesity. Diabetologia 1997;40:1204-1210.
12. Verma N, Jain V, Birla S, Jain R, Sharma A. Growth and hormonal profile from birth to adolescence of a girl with aromatase deficiency. J Pediatr Endocrinol Metab 2012;25:1185-1190.
13. Maffei L, Rochira V, Zirilli L, et al. A novel compound heterozygous mutation of the aromatase gene in an adult man: reinforced evidence on the relationship between congenital oestrogen deficiency, adiposity and the metabolic syndrome. Clin Endocrinol 2007;67:218-224.
14. Heine PA, Taylor JA, Iwamoto GA, Lubahn DB, Cooke PS. Increased adipose tissue in male and female estrogen receptor-knockout mice. Proc Natl Acad Sci USA 2000;97:12729-12734.
15. Musatov S, Chen W, Pfaff DW, et al. Silencing of estrogen receptor in the ventromedial nucleus of hypothalamus leads tometabolic syndrome. Proc Natl Acad Sci USA 2007;104:2501-2506.
16. Diano S, Kalra SP, Horvath TL. Leptin receptor immunoreactivity is associated with the Golgi apparatus of hypothalamic neurons and glial cells. J Neuroendocrinol 1998;10:647-650.
17. Clegg DJ, Brown LM, Woods SC, Benoit SC. Gonadal hormones determine sensitivity to central leptin and insulin. Diabetes 2006;55:978-987.
18. Augoulea A, Mastorakos G, Lambrinoudaki I, Christodoulakos G, Creatsas G. Role of postmenopausal hormone replacement therapy on body fat gain and leptin levels. Gynecol Endocrinol 2005;20:227-235.
19. Elbers JM, de Roo GW, Popp-Snijders C, et al. Effects of administration of 17A-oestradiol on serum leptin levels in healthy postmenopausal women. Clin Endocrinol (Oxf) 1999;51:449-454.
20. Wildman RP, Tepper PG, Crawford S, et al. Do changes in sex steroid hormones precede or follow increases in body weight during the menopause transition? Results from the Study of Women's Health Across the Nation. J Clin Endocrinol Metab 2012;97:E1695-E1704.
21. Weigle DS, Ganter SL, Kuijper JL, Leonetti DL, Boyko EJ, Fujimoto WY. Effect of regional fat distribution and Prader-Willi syndrome on plasma leptin levels. J Clin Endocrinol Metab 1997;82:566-570.
22. Mattiasson I, Rendell M, Törnquist C, Jeppsson S, Hulthén UL. Effects of estrogen replacement therapy on abdominal fat compartments as related to glucose and lipid metabolism in early postmenopausal women. Horm Metab Res 2002;34:583-588.
23. Cagnacci A, Malmusi S, Arangino S, et al. Influence of transdermal estradiol in the regulation of leptin levels of postmenopausal women: a double-blind, placebo-controlled study. Menopause 2002;9:65-71.
24. Yüksel H, Odabazi AR, Demircan S, et al. Effects of oral continuous 17Aestradiol plus norethisterone acetate replacement therapy on abdominal subcutaneous fat, serum leptin levels and body composition. Gynecol Endocrinol 2006;22:381-387.
25. Kristensen K, Pedersen SB, Vestergaard P, Mosekilde L, Richelsen B. Hormone replacement therapy affects body composition and leptin differently in obese and non-obese postmenopausal women. J Endocrinol 1999;163:55-62.
26. Lambrinoudaki IV, Christodoulakos GE, Panoulis CP, et al. Effect of hormone replacement therapy and tibolone on serum leptin levels in postmenopausal women. Maturitas 2004;48:107-113.
27. Castelo-Branco C, Palacios S, Vázquez F, et al. Effects on serum lipid and leptin levels of three different doses of norethisterone continuously combined with a fixed dose of 17A-estradiol for nasal administration in postmenopausal women: a controlled, double-blind study. Fertil Steril 2007;88:383-389.
28. Tommaselli GA, Di Carlo C, Di Spiezio Sardo A, et al. Serum leptin levels and body composition in postmenopausal women treated with tibolone and raloxifene. Menopause 2006;13:660-668.
29. Di Carlo C, Tommaselli GA, Sammartino A, Bifulco G, Nasti A, Nappi C. Serum leptin levels and body composition in postmenopausal women: effects of hormone therapy. Menopause 2004;11:466-473.
30. Dedeo?lu EN, Erenus M, Yörük P. Effects of hormone therapy and tibolone on body composition and serum leptin levels in postmenopausal women. Fertil Steril 2009;91:425-431.
31. Laivuori H, Koistinen HA, Karonen SL, Cacciatore B, Ylikorkala O. Comparison between 1 year oral and transdermal oestradiol and sequential norethisterone acetate on circulating concentrations of leptin in postmenopausal women. Hum Reprod 2001;16:1632-1635.
32. Konukoglu D, Serin O, Ercan M. Plasma leptin levels in obese and nonobese postmenopausal women before and after hormone replacement therapy. Maturitas 2000;36:203-207.
33. Petzel M, Stejskal D, Jedelsky L, Kadalova L, Safarcik K. The influence of estradiol and tibolone administration on leptin levels in women with surgically induced menopause. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2008;152:101-105.
34. Nar A, Demirtas E, Ayhan A, Gurlek A. Effects of bilateral ovariectomy and estrogen replacement therapy on serum leptin, sex hormone binding globulin and insulin like growth factor-I levels. Gynecol Endocrinol 2009;25:773-778.
35. Lavoie HB, Taylor AE, Sharpless JL, Anderson EJ, Strauss CC, Hall JE. Effects of short-term hormone replacement on serum leptin levels in postmenopausal women. Clin Endocrinol (Oxf) 1999;51:415-422.
36. Cento RM, Proto C, Spada RS, et al. Leptin levels in menopause: effect of estrogen replacement therapy. Horm Res 1999;52:269-273.
37. Tommaselli GA, Di Carlo C, Nasti A, et al. Effects of bilateral ovariectomy and postoperative hormonal replacement therapy with 17A-estradiol or raloxifene on serum leptin levels. Menopause 2003;10:160-164.
38. Gol M, Ozsener S, Sendag F, et al. Does tibolone affect serum leptin levels and body weight in postmenopausal women? Arch Gynecol Obstet 2005;272:127-130.
39. Di Carlo C, Tommaselli GA, Pisano G, et al. Serum leptin levels in postmenopausal women: effects of transdermal hormone replacement therapy. Menopause 2000;7:36-41.
40. Panidis DK, Rousso DH, Kourtis AI, Stergiopoulos KN, Mavromatidis GA, Katsikis IK. The influence of tibolone upon serum leptin levels in postmenopausal women. Eur J Obstet Gynecol Reprod Biol 2001;96:85-87.
41. Ainslie DA, Morris MJ, Wittert G, Turnbull H, Proietto J, Thorburn AW. Estrogen deficiency causes central leptin insensitivity and increased hypothalamic neuropeptide Y. Int J Obes Relat Metab Disord 2001;25: 1680-1688.
42. Kakolewski JW, Cox VC, Valenstein ES. Sex differences in body-weight change following gonadectomy of rats. Psychol Rep 1968;22:547-554.
43. Gao Q, Horvath TL. Cross-talk between estrogen and leptin signaling in the hypothalamus. Am J Physiol Endocrinol Metab 2008;294:E817-E826.
44. Myers MG Jr, Leibel RL, Seeley RJ, Schwartz MW. Obesity and leptin resistance: distinguishing cause from effect. Trends Endocrinol Metab 2010;21:643-651.
45. Johnson JR, Lacey JV Jr, Lazovich D, et al. Menopausal hormone therapy and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2009;18:196-203.
46. Cauley JA, Robbins J, Chen Z, et al. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. JAMA 2003;290:1729-1738.
47. Anderson GL, Chlebowski RT, Rossouw JE, et al. Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin. Maturitas 2006;55:103-115.
48. Cushman M, Kuller LH, Prentice R, et al. Estrogen plus progestin and risk of venous thrombosis. JAMA 2004;292:1573-1580.